Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-04-12 @ 9:03 PM
Study NCT ID:
NCT05946902
Status:
UNKNOWN
Last Update Posted:
2023-09-13
First Post:
2023-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study
Sponsor:
Far Eastern Memorial Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
112019-F
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None